Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pomeroy

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Nature Communications|November 21, 2019
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Nature Communications|April 24, 2021
CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cellsMitchell G Kluesner, Walker S Lahr, Cara-Lin Lonetree, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2019
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer ImmunotherapyEmily J Pomeroy, John T Hunzeker, Mitchell G Kluesner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine ProductionJames D Dahlvang, Jenna K Dick, Jules A Sangala, et al.
Oncogene|October 5, 2019
SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasisBranden A Smeester, Nicholas J Slipek, Emily J Pomeroy, et al.
Pediatric Obesity|February 1, 2019
Associations of sleep patterns with metabolic syndrome indices, body composition, and energy intake in children and adolescentsSarah J Mi, Nichole R Kelly, Robert J Brychta, et al.
Nature Communications|December 8, 2019
Author Correction: Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Journal for Immunotherapy of Cancer|May 9, 2025
Precision enhancement of CAR-NK cells through non-viral engineering and highly multiplexed base editingMinjing Wang, Joshua B Krueger, Alexandria K Gilkey, et al.
Bone|April 7, 2020
PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcomaBranden A Smeester, Nicholas J Slipek, Emily J Pomeroy, et al.
Haematologica|July 16, 2016
Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiencyZohar Sachs, Raha A Been, Krista J DeCoursin, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Nature Communications|November 21, 2019
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Nature Communications|April 24, 2021
CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cellsMitchell G Kluesner, Walker S Lahr, Cara-Lin Lonetree, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2019
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer ImmunotherapyEmily J Pomeroy, John T Hunzeker, Mitchell G Kluesner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine ProductionJames D Dahlvang, Jenna K Dick, Jules A Sangala, et al.
Oncogene|October 5, 2019
SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasisBranden A Smeester, Nicholas J Slipek, Emily J Pomeroy, et al.
Pediatric Obesity|February 1, 2019
Associations of sleep patterns with metabolic syndrome indices, body composition, and energy intake in children and adolescentsSarah J Mi, Nichole R Kelly, Robert J Brychta, et al.
Nature Communications|December 8, 2019
Author Correction: Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Journal for Immunotherapy of Cancer|May 9, 2025
Precision enhancement of CAR-NK cells through non-viral engineering and highly multiplexed base editingMinjing Wang, Joshua B Krueger, Alexandria K Gilkey, et al.
Bone|April 7, 2020
PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcomaBranden A Smeester, Nicholas J Slipek, Emily J Pomeroy, et al.
Haematologica|July 16, 2016
Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiencyZohar Sachs, Raha A Been, Krista J DeCoursin, et al.
Pageof 8